Shane Darke1, Johan Duflou2, Sharlene Kaye3. 1. National Drug and Alcohol Research Centre, University of New South Wales, NSW, 2052, Australia. Electronic address: s.darke@unsw.edu.au. 2. National Drug and Alcohol Research Centre, University of New South Wales, NSW, 2052, Australia; Sydney Medical School, University of Sydney, NSW, Australia. 3. National Drug and Alcohol Research Centre, University of New South Wales, NSW, 2052, Australia; Justice Health and Forensic Mental Health Network, NSW Justice Health, NSW Australia.
Abstract
BACKGROUND: Methamphetamine dependence is a major public health problem. This study examined the nature, and extent, of cardiovascular disease amongst cases of methamphetamine-related death in Australia, 2009-2015. METHODS: Analysis of 894 cases of methamphetamine-related death with full autopsy reports retrieved from the National Coronial Information System. RESULTS: The mean age was 37.9yrs (range 15-69yrs) and 78.5% were male. A quarter (26.3%) of cases had enlarged hearts and left ventricular hypertrophy was diagnosed in 18.9%. Severe coronary artery disease was present in 19.0%, the left coronary artery being the vessel most frequently stenosed (16.6%). Replacement fibrosis (evidence of earlier ischaemic events) in the heart muscle was observed in 19.8% of cases, and cardiomyopathy was diagnosed in 5.5%. Histological evidence of hypertension was observed in 32.7% of cases. With the exception of cardiomyopathy, equally common amongst both sexes, cardiovascular disease was more common amongst males, and those aged >35yrs. Clinically significant levels of cardiovascular disease were also observed amongst cases where the cause of death was not attributed to cardiovascular disease: cardiomegaly (19.3%), left ventricular hypertrophy (14.6%), severe coronary artery disease (9.4%), replacement fibrosis (14.4%), cardiomyopathy (3.3%). CONCLUSIONS: Cardiovascular disease was highly prevalent, despite the relatively young age of cases. With methamphetamine use increasing rapidly in major regions, cardiovascular disease and cardiovascular-related death will likely increase amongst methamphetamine users.
BACKGROUND:Methamphetamine dependence is a major public health problem. This study examined the nature, and extent, of cardiovascular disease amongst cases of methamphetamine-related death in Australia, 2009-2015. METHODS: Analysis of 894 cases of methamphetamine-related death with full autopsy reports retrieved from the National Coronial Information System. RESULTS: The mean age was 37.9yrs (range 15-69yrs) and 78.5% were male. A quarter (26.3%) of cases had enlarged hearts and left ventricular hypertrophy was diagnosed in 18.9%. Severe coronary artery disease was present in 19.0%, the left coronary artery being the vessel most frequently stenosed (16.6%). Replacement fibrosis (evidence of earlier ischaemic events) in the heart muscle was observed in 19.8% of cases, and cardiomyopathy was diagnosed in 5.5%. Histological evidence of hypertension was observed in 32.7% of cases. With the exception of cardiomyopathy, equally common amongst both sexes, cardiovascular disease was more common amongst males, and those aged >35yrs. Clinically significant levels of cardiovascular disease were also observed amongst cases where the cause of death was not attributed to cardiovascular disease: cardiomegaly (19.3%), left ventricular hypertrophy (14.6%), severe coronary artery disease (9.4%), replacement fibrosis (14.4%), cardiomyopathy (3.3%). CONCLUSIONS:Cardiovascular disease was highly prevalent, despite the relatively young age of cases. With methamphetamine use increasing rapidly in major regions, cardiovascular disease and cardiovascular-related death will likely increase amongst methamphetamine users.
Authors: Christopher G Kevil; Nicholas E Goeders; Matthew D Woolard; Md Shenuarin Bhuiyan; Paari Dominic; Gopi K Kolluru; Connie L Arnold; James G Traylor; A Wayne Orr Journal: Arterioscler Thromb Vasc Biol Date: 2019-08-21 Impact factor: 8.311
Authors: Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky Journal: Circ Arrhythm Electrophysiol Date: 2021-12-28
Authors: Shichao Tang; Christopher M Jones; April Wisdom; Hsien-Chang Lin; Sarah Bacon; Debra Houry Journal: Psychiatry Res Date: 2021-03-13 Impact factor: 3.222
Authors: Nicholas A Kolaitis; Roham T Zamanian; Vinicio A de Jesus Perez; David B Badesch; Raymond L Benza; Charles D Burger; Murali M Chakinala; Jean M Elwing; Jeremy Feldman; Matthew R Lammi; Stephen C Mathai; John W McConnell; Kenneth W Presberg; Jeffrey C Robinson; Jeffrey Sager; Oksana A Shlobin; Marc A Simon; Steven M Kawut; David V Glidden; Jonathan P Singer; Teresa De Marco Journal: Ann Am Thorac Soc Date: 2021-04